Prosecution Insights
Last updated: April 19, 2026
Application No. 17/999,752

RUMINANT FEED INCLUDING A FATTY ACID-PROTECTED PROTEIN

Non-Final OA §103
Filed
Nov 23, 2022
Examiner
LOVE, TREVOR M
Art Unit
1611
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Cargill Incorporated
OA Round
3 (Non-Final)
43%
Grant Probability
Moderate
3-4
OA Rounds
3y 6m
To Grant
68%
With Interview

Examiner Intelligence

Grants 43% of resolved cases
43%
Career Allow Rate
301 granted / 703 resolved
-17.2% vs TC avg
Strong +25% interview lift
Without
With
+24.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
36 currently pending
Career history
739
Total Applications
across all art units

Statute-Specific Performance

§101
2.4%
-37.6% vs TC avg
§103
50.9%
+10.9% vs TC avg
§102
18.9%
-21.1% vs TC avg
§112
14.6%
-25.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 703 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Acknowledgement is made to Applicant’s response filed 05/21/2025. Claims 1, 3, 6-9, and 11-21 are pending. Claims 2, 4, 5, and 10 are cancelled, with Claim 10 being newly cancelled. Claim 1 is currently amended. Claims 3 and 15-20 remain withdrawn. Claim 21 is newly added. Claims 1, 6-9, 11-14, and 21 are currently under consideration to the extent that they read upon Applicant’s elected species. Rejections Maintained and Made Again in view of Applicant’s Amendments with New Grounds for Newly Added Claim 21 Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1, 6-9, 11-14, and 21 (all claims currently under consideration) is/are rejected under 35 U.S.C. 103 as being unpatentable over Haussner et al (WO 2019/063669)(IDS Reference). Haussner teaches a composition for feeding to ruminants comprising a core and a coating surrounding said core (see entire document, for instance, claim 1). The core comprises a protein (see entire document for instance, claim 1), wherein the protein is taught as being selected from the group including soybean meal (see entire document, for instance, page 18, lines 4-5). The coating is made of a saturated fat, and specifically, hydrogenated palm oil, wherein the palm oil appears to be a free fatty acid (see entire document, for instance, claim 6). It is noted that saturated, hydrogenated palm oil would have an iodine value within the claimed range of less than 8 cg I2/g (note that instant claim 7 depends on claim 1 which asserts hydrogenated saturated palm oil falls within the scope of claim 1). The coating is taught as being present in an amount that includes 5%-30% of the total composition, wherein the protein would therefore be 95%-70% (see entire document, for instance, claim 1). Haussner further teaches that the amount of the composition in a final ruminant feed is a results effective variable with the amount predicated on the amount suitable to compensate for a lack of nutrients and essential amino acids in a ruminant diet (see entire document, for instance, page 25, lines 1-5). It is noted that the Haussner teaches heating the composition, coating the core, and then cooling the composition (see entire document, for instance, claim 13). It is noted that this is the same process that is indicated in the Instant Specification that results in the crystallization of the saturated, hydrogenated fatty acid around the protein core, therefore, the composition of the prior art is deemed to have the same crystallized hydrogenated, saturated fatty acid. Haussner, while teaching all of the instantly claimed components and amounts that overlaps with instantly claimed ranges, does not provide a singular example that expressly articulates all of said elements to the extent that the teaching rises to the level of anticipation. It would have been obvious to one of ordinary skill in the art, before the effective filing date of the instantly claimed invention, to utilize the components taught in Haussner for the purposes taught by Haussner and in the amounts taught by Haussner, and thereby arrive at the instantly claimed invention. One would have been motivated to do so since Haussner directly teaches that said components can be utilized and said amounts are useful. It is noted that MPEP 2144.05 states: "Generally, differences in concentration or temperature will not support the patentability of subject matter encompassed by the prior art unless there is evidence indicating such concentration or temperature is critical. “[W]here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation.” In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955).” Further, MPEP 2144.07 states “[t]he selection of a known material based on its suitability for its intended use supported a prima facie obviousness determination in Sinclair & Carroll Co. v. Interchemical Corp., 325 U.S. 327, 65 USPQ 297 (1945) […] “[r]eading a list and selecting a known compound to meet known requirements is no more ingenious than selecting the last piece to put in the last opening in a jig-saw puzzle.” 325 U.S. at 335, 65 USPQ at 301.)”. Response to Arguments Applicant argues in the Remarks filed 02/23/2026 that the prior art does not teach the newly claimed limitations regarding the iodine value, the coating of the soybean meal, or the crystallization around the particles of soybean meal. Applicant’s arguments are not found persuasive. Specifically, the prior art teaches the same process for coating the soybean meal particles, including the heating and cooling steps, wherein the composition would be coated and crystallization would occur. Further, with regard to the iodine value, it is noted that the instant specification teaches that hydrogenated saturated palm fatty acid has an iodine value of less than 8, wherein a product cannot be separated from its properties, wherein the prior art teaches hydrogenated saturated palm fatty acid, and therefore, would also have an iodine value of less than 8. It is noted that Applicant asserts that the iodine value is tied to the degree of saturation/unsaturation. It is further noted that the prior art indicates that the hydrogenated palm oil is saturated. For at least these reasons, Applicant’s arguments are not found persuasive. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to TREVOR M LOVE whose telephone number is (571)270-5259. The examiner can normally be reached M-F typically 6:30-3. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bethany Barham can be reached at 5712726175. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /TREVOR LOVE/Primary Examiner, Art Unit 1611
Read full office action

Prosecution Timeline

Nov 23, 2022
Application Filed
Aug 08, 2025
Non-Final Rejection — §103
Oct 09, 2025
Response Filed
Oct 23, 2025
Final Rejection — §103
Feb 23, 2026
Request for Continued Examination
Feb 24, 2026
Response after Non-Final Action
Mar 02, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599643
USE OF GREEN COFFEE BASED COMPOSITIONS FOR IMPROVING INSULIN PROFILE
2y 5m to grant Granted Apr 14, 2026
Patent 12599695
ABSORBABLE SUTURE CONTAINING POLYDEOXYRIBONUCLEOTIDE
2y 5m to grant Granted Apr 14, 2026
Patent 12594317
TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING NOVEL CORONAVIRUS PNEUMONIA, PREPARATION METHOD, DETECTION METHOD, AND USE THEREOF
2y 5m to grant Granted Apr 07, 2026
Patent 12575571
1-AMINO-1-CYCLOPROPANECARBOXYLIC ACID AND METHYL JASMONATE MIXTURES AND USES THEREOF
2y 5m to grant Granted Mar 17, 2026
Patent 12575563
SURFACTANTS FOR AGRICULTURAL PRODUCTS
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
43%
Grant Probability
68%
With Interview (+24.9%)
3y 6m
Median Time to Grant
High
PTA Risk
Based on 703 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month